Indication	Number of Patients (Percent of Total Patients Authorized to Obtain CBD)
Amyotrophic lateral sclerosis	26 (1%)
Acquired immune deficiency/human immunodeficiency virus	25 (1%)
Autism	10 (1%)
Cancer with cachexia or sever wasting	54 (2)
Cancer with nausea or chronic pain	265 (9%)
Crohn disease	101 (3%)
Multiple sclerosis	238 (8%)
Parkinson disease	178 (6%)
Seizures	185 (6%)
Terminal illness with pain	16 (1%)
Terminal illness with cachexia or wasting	5 (<1%)
Terminal illness with nausea or vomiting	4 (<1%)
Untreatable pain	1906 (61%)
Ulcerative colitis	11 (<1%)